[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100574629":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":37,"centralContacts":42,"locations":27,"responsibleParty":48,"collaborators":27,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":27,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":27,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":71,"overallStatus":75,"whyStopped":27,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":27},{"fullName":5,"class":6},"Tri-Service General Hospital","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Corticosteroid Injection and shockwave Therapy","EXPERIMENTAL","Participants received ultrasound-guided sacroiliac joint corticosteroid injections (1 ml SHINCORT INJ 10 MG\u002FML + 1 ml 2% Xylocaine). One week later, they began a three-week course of weekly extracorporeal shockwave therapy sessions (intensity: low to moderate, adjusted based on patient tolerance; frequency: 5 Hz; 2000 shocks per session).",[13,14],"Drug: Corticosteroids Triamcinolone Acetonide","Device: extracorporeal shockwave",{"label":16,"type":17,"description":18,"interventionNames":19},"Corticosteroid Injection and sham shockwave Therapy","SHAM_COMPARATOR","Participants received ultrasound-guided sacroiliac joint corticosteroid injections (1 ml SHINCORT INJ 10 MG\u002FML + 1 ml 2% Xylocaine). One week later, they began a three-week course of weekly extracorporeal shockwave therapy sessions (intensity: minimum setting on the device; frequency: 5 Hz; 2000 shocks per session).",[13,20],"Device: extracorporeal shockwave(minimum intensity)",[22,28,33],{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"DRUG","Corticosteroids Triamcinolone Acetonide","ultrasound-guided sacroiliac joint corticosteroid injections (1 ml SHINCORT INJ 10 MG\u002FML + 1 ml 2% Xylocaine)",[16,9],null,{"type":29,"name":30,"description":31,"armGroupLabels":32,"otherNames":27},"DEVICE","extracorporeal shockwave","a three-week course of weekly extracorporeal shockwave therapy sessions (intensity: low to moderate, adjusted based on patient tolerance; frequency: 5 Hz; 2000 shocks per session)",[9],{"type":29,"name":34,"description":35,"armGroupLabels":36,"otherNames":27},"extracorporeal shockwave(minimum intensity)","a three-week course of weekly extracorporeal shockwave therapy sessions (intensity: minimum setting on the device; frequency: 5 Hz; 2000 shocks per session)",[16],[38],{"name":39,"affiliation":40,"role":41},"Liang cheng Chen, MD, MS","Department of Physical Medicine and Rehabilitation, Tri-Service General","PRINCIPAL_INVESTIGATOR",[43],{"name":39,"role":44,"phone":45,"phoneExt":46,"email":47},"CONTACT","886-2-87923311","12922","clctsgh@yahoo.com.tw",{"type":41,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":27,"oldOrganization":27},"Liang-Cheng Chen","Clinical Professor","100574629","combined-corticosteroid-injections-and-shockwave-therapy-for-sacroiliac-joint-pain-100574629",false,"NCT06761768","Combined Corticosteroid Injections and Shockwave Therapy for Sacroiliac Joint Pain","Efficacy of Combining Corticosteroid Injections and Extracorporeal Shockwave Therapy in Patients With Sacroiliac Joint Pain","Inclusion Criteria:\n\n* Low back pain lasting for 3 months or more\n* Pain VAS score of 4 or higher\n* Three or more positive results in sacroiliac joint provocation tests\n* At least 50% pain relief following ultrasound-guided sacroiliac joint injection with local anesthetic\n\nExclusion Criteria:\n\n* Currently undergoing extracorporeal shockwave therapy in other areas\n* Suspected pain caused by other lumbar spine or hip joint conditions (e.g., lumbar spine or disc disorders, radicular pain, spondylolisthesis\u002Fdisc degeneration, hip arthritis)\n* Presence of complex comorbidities, including trauma, systemic infections (e.g., fever, chills, night sweats), local sacroiliac joint infections, autoimmune diseases, or immunosuppression\n* Sacroiliac joint injection therapy received within the past 6 months\n* Contraindications for extracorporeal shockwave therapy (e.g., cancer or current\u002Fprior infections at the treatment site, pacemakers, pregnancy, epilepsy, or coagulation disorders caused by disease or medication)\n* Impaired renal function preventing the administration of contrast agents for sacroiliac joint bone scanning","ALL","20 Years","75 Years",{"count":62,"type":63},44,"ESTIMATED","INTERVENTIONAL",[66],"NA","This study aims to investigate the combined use of corticosteroid injections and ESWT for SIJ pain.",[69,70],"Sacroiliac Joint Dysfunction","Sacroiliac Joint Pain",[69,72,73,74],"Sacroiliac joint pain","Steroid Injection","Extracorporeal shock wave therapy","NOT_YET_RECRUITING","2025-01-07",{"date":78,"type":79},"2025-01-09","ACTUAL",{"date":81,"type":63},"2025-08-01",{"date":83,"type":63},"2026-07-31",{"name":5,"class":6}]